Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
CRISPR Therapeutics AG | Salute | Rachel Elfman | Equity Analyst | 12/04/2024 | ||
Curaleaf Holdings Inc | Salute | Kristoffer Inton | Strategist | 12/04/2024 | ||
GSK PLC | Salute | Damien Conover | Sector Director | 11/04/2024 | ||
GSK PLC ADR | Salute | Damien Conover | Sector Director | 11/04/2024 | ||
Vertex Pharmaceuticals Inc | Salute | Rachel Elfman | Equity Analyst | 11/04/2024 | ||
China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | Salute | Yurou Zheng | Equity Analyst | 11/04/2024 | ||
Carl Zeiss Meditec AG | Salute | Keonhee Kim | Equity Analyst | 11/04/2024 | ||
Shanghai Pharmaceuticals Holding Co Ltd Class H | Salute | Yurou Zheng | Equity Analyst | 11/04/2024 | ||
AVITA Medical Inc | Salute | Shane Ponraj | Equity Analyst | 11/04/2024 | ||
Merck KGaA | Salute | Julie Utterback | Senior Equity Analyst | 10/04/2024 | ||
Merck KGaA ADR | Salute | Julie Utterback | Senior Equity Analyst | 10/04/2024 | ||
Tilray Brands Inc | Salute | Kristoffer Inton | Strategist | 09/04/2024 | ||
Sinohealth Holdings Ltd | Salute | Kai Wang | Senior Equity Analyst | 09/04/2024 | ||
Ansell Ltd | Salute | Shane Ponraj | Equity Analyst | 09/04/2024 | ||
Alibaba Health Information Technology Ltd | Salute | Kai Wang | Senior Equity Analyst | 08/04/2024 | ||
Johnson & Johnson | Salute | Damien Conover | Sector Director | 05/04/2024 | ||
CureVac NV Ordinary Shares | Salute | Rachel Elfman | Equity Analyst | 04/04/2024 | ||
Cochlear Ltd | Salute | Shane Ponraj | Equity Analyst | 04/04/2024 | ||
Genmab A/S | Salute | Rachel Elfman | Equity Analyst | 04/04/2024 | ||
Centene Corp | Salute | Julie Utterback | Senior Equity Analyst | 02/04/2024 |